Kusajili – Clinical trials directory

Result of your search per specialist: Prof Reinhard Heun

Woman and Man Max 99 years
Institut de Recherches Internationales Servier (France) Update Il y a 4 ans

Efficacy and safety of agomelatine oral administration (25 to 50 mg/day) in elderly patients suffering from major depressive disorder: an 8-week, randomised, double-blind, flexible-dose, parallel groups, placebo-controlled, international, multicentre study followed by an extension double-blind treatment period of 16 weeks Not provided at time of registration and not expected to be available in the future

Country None
organs None
Specialty None

Closed trial

More information